Polar Capital Holdings PLC Edwards Lifesciences Corp Transaction History

Polar Capital Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $1.47 Million - $1.88 Million	-21,505 Reduced 22.04%	76,063 $5.68 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $243,320 - $316,934	2,954 Added 3.12%	97,568 $8.06 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $178,622 - $264,877	-2,065 Reduced 2.14%	94,614 $9 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $213,708 - $269,000	2,096 Added 2.22%	96,679 $11.4 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $993,283 - $1.22 Million	9,338 Added 10.95%	94,583 $12.3 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $378,502 - $451,474	3,678 Added 4.51%	85,245 $9.65 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $6.84 Million - $8.54 Million	81,567 New	81,567 $8.45 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.